Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. (AXSM) Stock Overview

Explore Axsome Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AXSM●NASDAQ
HealthcareBiotechnology
$211.89
$0.85(0.40%)
U.S. Market is Open · 14:09

Axsome Therapeutics, Inc. (AXSM)

Meyka AI Score

Z

Key Financials

Market Cap10.9B
P/E Ratio-56.77
EPS (TTM)$-3.83
ROE-2.60%
Fundamental Analysis

AI Price Forecasts

1 Month$240.25
3 Months$248.54
1 Year Target$181.18

AXSM Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Axsome Therapeutics, Inc. (NASDAQ: AXSM) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Axsome Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of AXSM on the NASDAQ shows an RSI of 34.98, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $181.18 for the NASDAQ listing.

Key metrics behind Axsome Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -56.77 and a market capitalization of 10.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of AXSM on the NASDAQ.

Price Performance (NASDAQ: AXSM)

1-Day Change
0.54%
5-Day Change
-7.45%
1-Month Change
-12.54%
3-Month Change
-5.15%
6-Month Change
14.35%
Year-to-Date (YTD) Change
16.17%
1-Year Change
99.15%
3-Year Change
188.04%
5-Year Change
329.93%
All-Time (Max) Change
2327.57%

Contact Information

https://www.axsome.com
212 332 3241
One World Trade Center, New York City, NY, 10007

Company Facts

12,200 Employees
IPO DateNov 19, 2015
CountryUS
Actively Trading

Frequently Asked Questions